The above data indicated that OSBPL3 expression is significantly associated with the poor prognosis of patients with LGG, UVM, PAAD, and MESO cancers but differentially associated with other tumors and may act as a detrimental prognostic factor in these tumors, which is worth further exploration. Here, OSBPL3 is linked to pancreatic adenocarcinoma.